Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT03056391
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Clinical Research Center, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia | Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia | Hospital Queen Elizabeth, Malaysia

Active Ingredients

Drugs in Phase 3 Trials (2)

acetaminophen (tylenol) (1 trial)

doxycycline (vibramycin) (1 trial)

Drugs in Other Trials (1)

hypochlorous acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3